Lifeline BioTechnologies, Inc. Announces Capital Restructuring for Continued Growth and Potential Acquisitions: 1 for 1,600 Reverse Stock Split

RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) announced today it will be undertaking a capital restructuring to better position the Company for growth and expansion. Effective July 31, 2007, Lifeline Biotechnologies will be implementing a 1 for 1,600 reverse stock split of its outstanding common stock, subject to completion of regulatory compliance requirements.

MORE ON THIS TOPIC